Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov 6:10:265-273.
doi: 10.2147/CEG.S105872. eCollection 2017.

Primary sclerosing cholangitis: diagnostic and management challenges

Affiliations
Review

Primary sclerosing cholangitis: diagnostic and management challenges

Sanjeev Sirpal et al. Clin Exp Gastroenterol. .

Abstract

Primary sclerosing cholangitis (PSC) is a chronic immune-mediated disease affecting intra- and extrahepatic bile ducts, primarily the large biliary ducts. Clinical manifestations are broad, and the spectrum encompasses asymptomatic cholestasis, icteric cholangitis with pruritis, cirrhosis, and cholangiocarcinoma. Though rare, PSC has a propensity to affect young to middle-aged males and is strongly associated with inflammatory bowel disease. There is an unmet need for effective medical treatments for PSC, and to date, the only curative therapy is liver transplantation reserved for those with end-stage liver disease. This article addresses the diagnostic and management challenges of PSC, with a succinct analysis of existing therapies, their limitations, and a glimpse into the future of the management of this multifaceted pathologic entity.

Keywords: PSC; management; primary sclerosing cholangitis.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

    1. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2009;51(2):660–678. - PubMed
    1. Lindor K, Kowdley K, Harrison M. ACG clinical guideline: primary sclerosing cholangitis. Am J Gastroenterol. 2015;110(5):646–659. - PubMed
    1. Rea DJ, Heimbach JK, Rosen CB, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg. 2005;242(3):451–461. - PMC - PubMed
    1. Lee Y, Kaplan M. Primary sclerosing cholangitis. N Engl J Med. 1995;332(14):924–933. - PubMed
    1. Angulo P, Lindor K. Primary sclerosing cholangitis. Hepatology. 1999;30(1):325–332. - PubMed